Michael Jerman

Michael Jerman

Director/Board Member at INHIBITOR THERAPEUTICS, INC.

Net worth: 7 076 $ as of 31/05/2024

40 year
Consumer Services
Health Technology
Commercial Services

Profile

Mr. Michael Jerman is an Independent Director at Telomir Pharmaceuticals, Inc., an Independent Director at Inhibitor Therapeutics, Inc. and a Managing Partner at Hollywell Partners LLC.
He is on the Board of Directors at MIRA Pharmaceuticals, Inc., Telomir Pharmaceuticals, Inc. and Inhibitor Therapeutics, Inc. Mr. Jerman also served on the board at PricewaterhouseCoopers LLP.
He received his undergraduate degree from the University of South Florida, a graduate degree from The University of Tampa, Inc. and an MBA from the University of Oxford.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
01/04/2024 80,411 ( 0.05% ) 7 076 $ 31/05/2024
01/04/2024 0 ( -.--% ) - $ 31/05/2024

Michael Jerman active positions

CompaniesPositionStart
INHIBITOR THERAPEUTICS, INC. Director/Board Member 24/05/2023
MIRA PHARMACEUTICALS, INC. Director/Board Member 14/11/2023
All active positions of Michael Jerman

Former positions of Michael Jerman

CompaniesPositionEnd
Director/Board Member 01/08/2019
See the detail of Michael Jerman's experience

Training of Michael Jerman

University of South Florida Undergraduate Degree
The University of Tampa, Inc. Graduate Degree
University of Oxford Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Jerman's experience

Connections

100 +

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
INHIBITOR THERAPEUTICS, INC.

Health Technology

MIRA PHARMACEUTICALS, INC.

Health Technology

Private companies1

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Michael Jerman